After finding out she had an MPN, Barbara Abernathy, Ph.D., like many other people, felt numb. But then it was time to find her fight mode.
Barbara Abernathy, Ph.D., CEO of the Pediatric Oncology Support Team, discusses the emotions she went through when she was first diagnosed with a myeloproliferative neoplasm.
Abernathy said that she, like many people, “went numb” when first hearing of her diagnosis, and that she had six months to live. However, shortly after she went into fight mode because to her, “dying was not an option.”
FDA Approves Ojjaara to Treat Myelofibrosis With Anemia
September 15th 2023The FDA approved Ojjaara for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anemia.
Read More